Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Dumba$$e$ Posting that which is not know ...
View:
Post by TreborTheGreat on Oct 03, 2023 8:44am

Dumba$$e$ Posting that which is not know ...

People you have no idea the terms of the TLRY settlement other than the $3MM cash

The rest is awash in uncertainty.  Might be great. Might be bad.

I suggesting waiting till the CC and asking.  Key questions ....

1) Transfer pricing method for inventory please?
2) How much TLRY stock for $4.5MM?  What are the lock up terms if any?
3) When you say "anticipated proceeds" of $4,5MM does that mean immediate sale??????
4) Is the purchase contract by TLRY to MEDIF just $500K or is there any other business linked to that?
Comment by subaru1i on Oct 03, 2023 9:16am
your post brings up good points TreborTheGreat but your approach is confrontational towards other posters that may have the same questions.  It would be wonderful if your post stated those points and that you are contemplating calling in on the next CC to ask these questions.   A negative emotional construct approach will yield less results than an emotional construct with a ...more  
Comment by alleyesonme on Oct 03, 2023 9:50am
No IDEA you say? Read the PR!  What has tilray been trading at recently? That can give you an IDEA of how many shares!    Trebor, does Labs balance suggest this stock need be liquidated immediately? Yes trebor, as stated in the PR the current agreement is up to 500k over 4 years, obviously this business relationship could expand this is a MINIMUM as stated in the PR. And what are ...more  
Comment by subaru1i on Oct 03, 2023 10:12am
I see the settlement as very positive, not only was it a settlement on a legal matter but LABS also developed a new customer for future growth, or 'this business relationship could expand'.   As stated in the Tilray press release on their micro breweries deal closing was ever allowed by the FDA to create non-alcoholic beverages ;-), they would at a minimum need an FDA approved ...more  
Comment by okgonow on Oct 03, 2023 10:41am
and thats why i made the point of LABS beeing in the drivers seat when it comes to needing an FDA aproved source for distillate?. if Tilray wants to infuse their beverages in the US. (they need LABS unless i am wrong and they can use amny of the others??) they didnt have to do the $500k in future contracts to establish a relationship with Tilray..... you are the one always saying that LABS is ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities